Bertin Pharma Bertin Pharma
logo
Select your search
Contact us
You are here : Bertin Pharma focuses its offer on providing Bioreagents & Bioanalytical Tools

Bertin Pharma focuses its activity on providing Bioreagents & Bioanalytical Tools

Bertin Pharma refocus on Bioreagent & Bionalytical Tools providing

On August 2017, Bertin Pharma has signed an agreement for the sale of its pre-clinical and clinical studies’ activities.

CNIM Group, Bertin Pharma’s main shareholder, decided to focus on its strategic product ranges: providing Bioreagents & Bioanalytic Tools. Those markets are more in tune with its industrial core activities in the fields of energy, environment, defense and security.

Bertin Pharma continues to be your partner for…

Bioreagents and Bioanalytical tools supplier

Bertin Pharma keeps on offering you 20 000 product references for your researches which applications applied to metabolism, cardiovascular diseases, cancer, immunology or inflammation and even more…

Product pipeline & out-licencing

Bertin Pharma proposes new innovative formulations combining safety and comfort of use for the patients.
Based on this know-how, we offer MA dossiers for therapeutics indications in relation with pain, coughs, cold, gastro-intestinal problem or allergies.

Your Partners for pharmaceutical development & non-clinical / clinical services

The buyers are two French companies. These purchases of goodwill are integrated into their strategic development plans. AmatsiGroup and Oncodesign are pure players in their fields. This dimension, not least, ensures the sustainability and quality of services.

Read the Press Release in English

Read the Press Release in French

Oncodesign

Oncodesign, leading French biopharmaceutical company, takes over Bertin Pharma's clinical and non-clinical services providing.

This purchase of goodwill is integrated into its strategic development plans.

Oncodesign is a pure player in its field. This dimension, not least, ensures the sustainability and quality of services.

Services:

  • Drug Discovery & Translational Research
  • Drug Analysis & Bioanalysis
  • Non Clinical Studies
  • Clinical Studies
  • Biobanking
  • Biosafety
  • Biocidal activity & biodecontamination

I want to know more

AmatsiGroup

AmatsiGroup takes over activities related to pharmaceutical development within its AmatsiAquitaine subsidiary:

  • Pre-formulation & Formulation
  • Innovative Technologies
  • Industrial Transfer
  • Manufacturing & Packaging
  • Clinical supplies & Quality control
  • Analytical development & Stabilities

I want to know more

About Oncodesign

Oncodesign is a leading biopharmaceutical company.

Oncodesign has built up an industrial model of innovation to orientate new therapeutic molecules to fight against cancers and other serious diseases without effective treatment to date: through services, partnerships and licensing, Oncodesign offers access to its drug discovery platform to qualify, at a very early stage, each molecule’s potential to become an effective therapeutic drug.

Based on a large portfolio of more than 600 clients and relying of the expertise of its 165 highly skilled personnel, Oncodesign meets the needs of innovation in the health industry through precision medicine.

Oncodesign is headquartered in Dijon and within the Paris-Saclay cluster with subsidiaries in Canada and USA.

Contact Oncodesign

About AmatsiGroup

AmatsiGroup, is a Contract Development and Manufacturing Organization (CDMO).

AmatsiGroup provides high-quality, customized and cost-effective drug development solutions, integrated under one roof, to small biotech and major (bio) pharmaceutical customers. Its innovative and flexible approach enables customers to speed up their drug development process, achieving key milestones in a timely manner.

With 400 highly qualified staff and a diversified clientele of 300 international pharmaceutical groups and biotech companies, AmatsiGroup is a leading provider of services for the development of veterinary and human pharmaceutical products.

AmatsiGroup is headquartered in France with 9 operational sites located in Europe and USA.

Contact AmatsiGroup

top

Bertin Pharma - Institutionnel

Follow Us

Linkedin Youtube Twitter Google+

Contact us

Any project? Any challenge? We are in!
+33 (0) 139 306 036
Any questions? Contact us

Headquarters:
Parc d’Activités du Pas du Lac
10 bis avenue Ampère
78180 Montigny le Bretonneux - France
Find us

Newsletter

Do you want to be kept updated with Bertin Pharma's latest news?

Manage my subscriptions